{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:08:04Z","timestamp":1786460884797,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41440-018-0024-6","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T06:37:44Z","timestamp":1521009464000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic significance of home pulse pressure for progression of diabetic nephropathy: KAMOGAWA-HBP study"],"prefix":"10.1038","volume":"41","author":[{"given":"Noriyuki","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Ushigome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Oyabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Ushigome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565\u201376.","journal-title":"N Engl J Med."},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"WC Cushman","year":"2010","unstructured":"ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Jr GoffDC, Jr GrimmRH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575\u201385.","journal-title":"N Engl J Med."},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/HYPERTENSIONAHA.110.162123","volume":"57","author":"TJ Niiranen","year":"2011","unstructured":"Niiranen TJ, Johansson JK, Reunanen A, Jula AM. Optimal schedule for home blood pressure measurement based on prognostic data: The finn-home study. Hypertension. 2011;57:1081\u20136.","journal-title":"Hypertension."},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1001\/archinte.160.21.3301","volume":"160","author":"A Hozawa","year":"2000","unstructured":"Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch Intern Med. 2000;160:3301\u20136.","journal-title":"Arch Intern Med."},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ajh\/hpt290","volume":"27","author":"S Hoshide","year":"2014","unstructured":"Hoshide S, Kario K, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Matsui Y, Nakamura A, Fukutomi M, Eguchi K, Ishikawa J, J-HOP Study Group. Association of morning and evening blood pressure at home with Asymptomatic organ damage in the J-HOP study. Am J Hypertens. 2014;27:939\u201347.","journal-title":"Am J Hypertens."},{"key":"24_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","volume":"100","author":"SS Franklin","year":"1999","unstructured":"Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354\u201360.","journal-title":"Circulation."},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2015.10.084","volume":"67","author":"S Selvaraj","year":"2016","unstructured":"Selvaraj S, Steg PG, Elbez Y, Sorbets E, Feldman LJ, Eagle KA, Ohman EM, Blacher J, Bhatt DL, REACH Registry Investigators. Pulse pressure and risk for cardiovascular events in patients with atherothrombosis from the REACH registry. J Am Coll Cardiol. 2016;67:392\u2013403.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jacc.2016.07.754","volume":"68","author":"JW McEvoy","year":"2016","unstructured":"McEvoy JW, Chen Y, Rawlings A, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control. J Am Coll Cardiol. 2016;68:1713\u201322.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2337\/diacare.28.1.95","volume":"28","author":"S Nakano","year":"2005","unstructured":"Nakano S, Konishi K, Furuya K, Uehara K, Nishizawa M, Nakagawa A, Kigoshi T, Uchida K. A prognostic role of mean 24-h pulse pressure level for cardiovascular events in type 2 diabetic subjects under 60 years of age. Diabetes Care. 2005;28:95\u2013100.","journal-title":"Diabetes Care."},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/HJH.0b013e328344d9cf","volume":"29","author":"K Hurk van den","year":"2011","unstructured":"van den Hurk K, Magliano DJ, Alssema M, Schlaich MP, Atkins RC, Reutens AT, Nijpels G, Dekker JM, Shaw JE. Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study. J Hypertens. 2011;29:953\u201360.","journal-title":"J Hypertens."},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00125-009-1262-6","volume":"52","author":"ST Knudsen","year":"2009","unstructured":"Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL. Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia. 2009;52:698\u2013704.","journal-title":"Diabetologia."},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/00004872-200209000-00017","volume":"20","author":"MT Schram","year":"2002","unstructured":"Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CD. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens. 2002;20:1743\u201351.","journal-title":"J Hypertens."},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0895-7061(01)02281-6","volume":"15","author":"ST Knudsen","year":"2002","unstructured":"Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens. 2002;15:244\u201350.","journal-title":"Am J Hypertens."},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/hr.2015.125","volume":"39","author":"YM Gu","year":"2016","unstructured":"Gu YM, Petit T, Wei FF, Thijs L, Jacobs L, Zhang ZY, Yang WY, Cauwenberghs N, Knez J, StruijkerBoudier HA, Kuznetsova T, Verhamme P, Staessen JA. Renal glomerular dysfunction in relation to retinal arteriolar narrowing and high pulse pressure in seniors. Hypertens Res. 2016;39:138\u201343.","journal-title":"Hypertens Res."},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.diabres.2013.07.005","volume":"101","author":"E Ushigome","year":"2013","unstructured":"Ushigome E, Fukui M, Hamaguchi M, Matsumoto S, Mineoka Y, Nakanishi N, Senmaru T, Yamazaki M, Hasegawa G, Nakamura N. Morning pulse pressure is associated more strongly with elevated albuminuria than systolic blood pressure in patients with type 2 diabetes mellitus: Post hoc analysis of a cross-sectional multicenter study. Diabetes Res Clin Pract. 2013;101:270\u20137.","journal-title":"Diabetes Res Clin Pract."},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00380-010-0107-z","volume":"26","author":"E Ushigome","year":"2011","unstructured":"Ushigome E, Fukui M, Sakabe K, Tanaka M, Inada S, Omoto A, Tanaka T, Fukuda W, Atsuta H, Ohnishi M, Mogami S, Kitagawa Y, Oda Y, Yamazaki M, Hasegawa G, Nakamura N. Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes. Heart Vessels. 2011;26:609\u201315.","journal-title":"Heart Vessels."},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10157-015-1088-0","volume":"19","author":"Y Nakade","year":"2015","unstructured":"Nakade Y, Toyama T, Furuichi K, Kitajima S, Miyajima Y, Fukamachi M, Sagara A, Shinozaki Y, Hara A, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Impact of kidney function and urinary protein excretion on intima\u2013media thickness in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2015;19:909\u201317.","journal-title":"Clin Exp Nephrol."},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1097\/01.ASN.0000146423.71226.0C","volume":"15","author":"G Remuzzi","year":"2004","unstructured":"Remuzzi G. Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results. J Am Soc Nephrol. 2004;15:3117\u201325.","journal-title":"J Am Soc Nephrol."},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00004872-200103000-00020","volume":"19","author":"SM Voyaki","year":"2001","unstructured":"Voyaki SM, Staessen JA, Thijs L, Wang JG, Efstratopoulos AD, Birkenh\u00e4ger WH, de Leeuw PW, Leonetti G, Nachev C, Rodicio JL, Tuomilehto J, Fagard R, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens. 2001;19:511\u20139.","journal-title":"J Hypertens."},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","year":"2003","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the description of diabetes categories of glucose. Diabetes Care. 2003;26:5\u201320. suppl 1","journal-title":"Diabetes Care."},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann J, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hall\u00e9 JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure. J Am Med Assoc. 2001;286:421\u20136.","journal-title":"J Am Med Assoc."},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.HYP.0000171189.48911.18","volume":"46","author":"H Kramer","year":"2005","unstructured":"Kramer H, Jacobs DR, Bild D, Post W, Saad MF, Detrano R, Tracy R, Cooper R, Liu K. Urine albumin excretion and subclinical cardiovascular disease: The multi-ethnic study of atherosclerosis. Hypertension. 2005;46:38\u201343.","journal-title":"Hypertension."},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2337\/dc13-0985","volume":"37","author":"AS Krolewski","year":"2014","unstructured":"Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014;37:226\u201334.","journal-title":"Diabetes Care."},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.diabres.2007.01.053","volume":"77","author":"H Yasuda","year":"2007","unstructured":"Yasuda H, Sanada M, Kitada K, Kitajima S, Miyajima Y, Fukamachi M, Sagara A, Shinozaki Y, Hara A, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007;77:S178\u2013S183.","journal-title":"Diabetes Res Clin Pract."},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/hr.2012.56","volume":"35","author":"Y Imai","year":"2012","unstructured":"Imai Y, Kario K, Shimada K, Kawano Y, Hasebe N, Matsuura H, Tsuchihashi T, Ohkubo T, Kuwajima I, Miyakawa M, Japanese Society of Hypertension Committee for Guidelines for Self-monitoring of Blood Pressure at Home. The Japanese Society of Hypertension Guidelines for self-monitoring of blood pressure at home (Second Edition). Hypertens Res. 2012;35:777\u201395.","journal-title":"Hypertens Res."},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.mbp.0000189788.05736.5f","volume":"11","author":"A Coleman","year":"2006","unstructured":"Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit. 2006;11:27\u201332.","journal-title":"Blood Press Monit."},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/eurheartj\/ehi467","volume":"26","author":"G Assmann","year":"2005","unstructured":"Assmann G, Cullen P, Evers T, Petzinna D, Schulte H. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J. 2005;26:2120\u20136.","journal-title":"Eur Heart J."},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1464-5491.2007.02197.x","volume":"24","author":"ST Knudsen","year":"2007","unstructured":"Knudsen ST, Jeppesen P, Frederiksen CA, Andersen NH, Bek T, Ingerslev J, Mogensen CE, Poulsen PL. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects. Diabet Med. 2007;24:911\u20135.","journal-title":"Diabet Med."},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/S0735-1097(03)00295-X","volume":"41","author":"R Ceravolo","year":"2003","unstructured":"Ceravolo R, Maio R, Pujia A, Sciacqua A, Ventura G, Costa MC, Sesti G, Perticone F. Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol. 2003;41:1753\u20138.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/01.HYP.0000171165.80268.be","volume":"46","author":"J Amar","year":"2005","unstructured":"Amar J, Ruidavets JB, Peyrieux JC, Mallion JM, Ferri\u00e8res J, Safar ME, Chamontin B. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects. Hypertension. 2005;46:151\u20135.","journal-title":"Hypertension."},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00125-007-0918-3","volume":"51","author":"CD Stehouwer","year":"2008","unstructured":"Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527\u201339.","journal-title":"Diabetologia."},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2006.12.050","volume":"50","author":"MF O\u2019Rourke","year":"2007","unstructured":"O\u2019Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007;50:1\u201313.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0735-1097(01)01108-1","volume":"37","author":"AM Dart","year":"2001","unstructured":"Dart AM, Kingwell BA. Pulse pressure\u2014a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37:975\u201384.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/01.HYP.0000114571.75762.b0","volume":"43","author":"ME Safar","year":"2004","unstructured":"Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163\u20138.","journal-title":"Hypertension."},{"key":"24_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.HYP.0000232645.97005.0e","volume":"48","author":"ST Knudsen","year":"2006","unstructured":"Knudsen ST, Andersen NH, Mogensen CE. Ambulatory pulse pressure and progression of albuminuria in type 2 diabetes: Evidence provided, new questions emerge. Hypertension. 2006;48:207\u20138.","journal-title":"Hypertension."},{"key":"24_CR36","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.2337\/dc08-0168","volume":"31","author":"K Hamano","year":"2008","unstructured":"Hamano K, Nitta A, Ohtake T, Kobayashi S. Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care. 2008;31:1853\u20137.","journal-title":"Diabetes Care."},{"key":"24_CR37","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.111.177469","volume":"58","author":"J Hashimoto","year":"2011","unstructured":"Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: Pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58:839\u201346.","journal-title":"Hypertension."},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jacc.2016.01.037","volume":"67","author":"K Kario","year":"2016","unstructured":"Kario K, Saito I, Kushiro T, Teramukai S, Tomono Y, Okuda Y, Shimada K. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST study. J Am Coll Cardiol. 2016;67:1519\u201327.","journal-title":"J Am Coll Cardiol."},{"key":"24_CR39","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.CIR.79.4.733","volume":"79","author":"JE Muller","year":"1989","unstructured":"Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733\u201343.","journal-title":"Circulation."},{"key":"24_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.116.07201","volume":"68","author":"S Hoshide","year":"2016","unstructured":"Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Matsui Y, Nakamura A, Fukutomi M, Eguchi K, Ishikawa J, Kario K, J-HOP Study Group. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese General Practice Population: the Japan morning surge-home blood pressure study. Hypertension. 2016;68:54\u201361.","journal-title":"Hypertension."},{"key":"24_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/hr.2016.87","volume":"40","author":"T Kushiro","year":"2017","unstructured":"Kushiro T, Kario K, Saito I, Teramukai S, Sato Y, Okuda Y, Shimada K. Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study. Hypertens Res. 2017;40:87\u201395.","journal-title":"Hypertens Res."},{"key":"24_CR42","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, M.D. for the SAVOR-TIMI 53 Streering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369:1317\u201326.","journal-title":"N Engl J Med."},{"key":"24_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Eoerle HJ, Broedl UC, Zinman B, EMPA-REG OUTCOME investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:323\u201334.","journal-title":"N Engl J Med."},{"key":"24_CR44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR, CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644\u201357. for","journal-title":"N Engl J Med."},{"key":"24_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/HJH.0b013e328319917e","volume":"27","author":"NV Hoeven van der","year":"2009","unstructured":"van der Hoeven NV, van den Born BJ, Cammenga M, van Montfrans GA. Poor adherence to home blood pressure measurement schedule. J Hypertens. 2009;27:275\u20139.","journal-title":"J Hypertens."},{"key":"24_CR46","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.2337\/diacare.26.9.2702","volume":"26","author":"ME Molitch","year":"2003","unstructured":"Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2003;26:S94\u2013S98.","journal-title":"Diabetes Care."},{"key":"24_CR47","doi-asserted-by":"publisher","first-page":"H1136","DOI":"10.1152\/ajpheart.00739.2014","volume":"308","author":"RE Climie","year":"2015","unstructured":"Climie RE, Srikanth V, Keith LJ, Davies JE, Sharman JE. Exercise excess pressure and exercise -induced albuminuria in patients with type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2015;308:H1136\u2013H1142.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"24_CR48","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.2337\/dc13-0189","volume":"36","author":"W Zhao","year":"2013","unstructured":"Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care. 2013;36:3287\u201396.","journal-title":"Diabetes Care."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0024-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0024-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:39Z","timestamp":1684617519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0024-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0024-6","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"10 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compilance with ethical standards"}},{"value":"NK, EU, SM, CO, MT, MY, and MF have received grant and research support from AstraZeneca plc, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., Kyowa Hakko Kirin Company Ltd., Kowa Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corp., Novo Nordisk Pharma Ltd., Nippon Chemiphar Company Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Sanofi K.K., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and TERUMO Co. The remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}